Loading…
Medline Inc. is projected to rise to $49.45 by 2027, a +21% move from its current price of $41.04. MDLN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $40.02 | $41.04 | $42.10 | +0.01% |
| Jul 14 | $39.60 | $41.05 | $42.55 | +0.02% |
| Jul 15 | $39.29 | $41.05 | $42.90 | +0.03% |
| Jul 16 | $39.03 | $41.06 | $43.19 | +0.04% |
| Jul 17 | $38.80 | $41.06 | $43.46 | +0.05% |
| Jul 18 | $38.59 | $41.07 | $43.70 | +0.06% |
| Jul 19 | $38.40 | $41.07 | $43.92 | +0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $38.40 | $41.07 | $43.92 | +0.07% |
| Week 2 | $37.38 | $41.10 | $45.19 | +0.14% |
| Week 3 | $36.62 | $41.13 | $46.20 | +0.22% |
| Week 4 | $35.99 | $41.16 | $47.07 | +0.29% |
| Week 5 | $35.45 | $41.19 | $47.85 | +0.36% |
| Week 6 | $34.97 | $41.22 | $48.58 | +0.43% |
| Week 7 | $34.54 | $41.25 | $49.26 | +0.51% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally.
It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories including surgical solutions, front line care, and laboratory and diagnostics.
Its Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands, and provides logistics and supply chain optimization services to domestic and international consumers. The company was founded in 1966 and is based in Northfield, Illinois.
Medline Inc. (MDLN) currently trades at $41.73 per share with a market cap of $74.35B and holds a rank of 217.
The near-term forecast for 2026 shows a neutral sentiment, with a min of $33.19, an avg of $41.73, a max of $55.66, and ROI 0.
Looking further ahead, the forecast envisions a rising path with increasing average prices and positive ROIs, culminating in 2050 with an avg of $276.12 and an ROI of 561.7 alongside a bullish stance.
Overall, the trajectory suggests upside through the late 2020s and beyond, with a bullish long-run outlook despite near-term uncertainty.
A major floor 29.0% below — a decisive break under it would weaken the trend.
The nearest floor, 19.1% below — buyers have tended to step in here.
The nearest ceiling, 5.2% above — a clean break opens room to run.
A major ceiling 19.7% above — clearing it would confirm fresh momentum.
Key MDLN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MDLN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $41.59 | Sell | $41.16 | Sell |
| MA 10 | $41.08 | Sell | $40.60 | Buy |
| MA 20 | $38.76 | Buy | $39.47 | Buy |
| MA 50 | $38.39 | Buy | $39.35 | Buy |
| MA 100 | $41.69 | Sell | $40.46 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.94 | Neutral |
| Stoch RSI (14) | 60.06 | Neutral |
| CCI (20) | 65.55 | Neutral |
| Williams %R (14) | -25.35 | Info |
| MACD (12,26,9) | 0.40 | Buy |
| ROC (12) | 16.26 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 74.65 | Neutral |
| TRIX (15) | 0.29 | Buy |
| Awesome (5,34) | 4.17 | Buy |
| Ultimate (7,14,28) | 62.15 | Neutral |
| Momentum (10) | 3.27 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 41.06 | Sell |
| ADX (14) | 21.29 | Buy |
| ATR (14) | 0.92 | Info |
The 30-day picture is bullish in view of the current momentum indicators. RSI14 is at 70, and the price is trading around the 50-day simple moving average at $38.87, with a bullish bias.
Key levels place the stock near resistance at $41.73 and above a support level of $33.19. The 30-day trading range spans from $35.34 to $49.27, giving a sense of recent volatility within the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $33.19 | $41.04 | $54.32 | 0% | Neutral | |
| $37.93 | $49.45 | $69.01 | +21% | Bullish | |
| $40.14 | $54.50 | $79.84 | +33% | Bullish | |
| $45.99 | $64.60 | $98.29 | +57% | Bullish | |
| $48.87 | $70.77 | $111.11 | +72% | Bullish | |
| $47.32 | $70.46 | $113.69 | +72% | Bullish | |
| $49.70 | $75.97 | $125.61 | +85% | Bullish | |
| $50.26 | $78.77 | $133.12 | +92% | Bullish | |
| $54.26 | $87.07 | $150.14 | +112% | Bullish | |
| $64.10 | $105.26 | $184.90 | +156% | Bullish | |
| $71.72 | $131.04 | $248.65 | +219% | Bullish | |
| $129.18 | $286.77 | $607.67 | +599% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $33.19 | $41.04 | $48.59 | +0.00% |
| August 2026 | $33.72 | $40.23 | $49.61 | -1.96% |
| September 2026 | $34.38 | $41.43 | $51.86 | +2.97% |
| October 2026 | $34.16 | $41.51 | $52.63 | +0.21% |
| November 2026 | $33.51 | $41.01 | $52.55 | -1.20% |
| December 2026 | $34.07 | $41.98 | $54.32 | +2.37% |
Click any year to see its month-by-month MDLN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MDLN could reach as high as $54.32, with a base case around $41.04 and support toward $33.19 — roughly 0% from $41.04. Price action looks broadly range-bound.
Expect MDLN to range from $37.93 to $69.01 through 2027. The $49.45 average target implies a +21% move from current prices. That is up +21% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The MDLN price prediction for 2028 points to an average of $54.50 (low $40.14, high $79.84) — a potential gain of +33% on today's $41.04. Momentum favours further upside here.
In 2029, MDLN is projected to trade between $45.99 and $98.29, averaging $64.60 — a potential gain of +57% from today's $41.04. That is up +19% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Medline Inc.'s 2030 outlook centres on $70.77, within a $48.87 to $111.11 range. That is up +10% on the projected 2029 average. That marks a +72% change versus current levels. Momentum favours further upside here.
By 2031, MDLN could reach as high as $113.69, with a base case around $70.46 and support toward $47.32 — roughly +72% from $41.04. Buyers look set to stay in control over this stretch.
Expect MDLN to range from $49.70 to $125.61 through 2032. The $75.97 average target implies a +85% move from current prices. That is up +8% on the projected 2031 average. Momentum favours further upside here.
The MDLN price prediction for 2033 points to an average of $78.77 (low $50.26, high $133.12) — a potential gain of +92% on today's $41.04. Buyers look set to stay in control over this stretch.
In 2034, MDLN is projected to trade between $54.26 and $150.14, averaging $87.07 — a potential gain of +112% from today's $41.04. That is up +11% on the projected 2033 average. Momentum favours further upside here.
Medline Inc.'s 2035 outlook centres on $105.26, within a $64.10 to $184.90 range. That is up +21% on the projected 2034 average. That marks a +156% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, MDLN could reach as high as $248.65, with a base case around $131.04 and support toward $71.72 — roughly +219% from $41.04. Momentum favours further upside here.
Expect MDLN to range from $129.18 to $607.67 through 2050. The $286.77 average target implies a +599% move from current prices. That is up +119% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MDLN today (≈ 24.366472 MDLN) could be worth
$6,987.69
+$5,987.69 (+599%) by 2050 · US Dollar
Based on the average projected MDLN price of $286.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MDLNwould be worth at today's price.
$1,000 invested in MDLN on Dec 17, 2025 (≈ 24.390244 MDLN) would be worth
$1,000.98
+$0.98 (+0.1%) today · 1.00× · US Dollar
Based on a MDLN entry price of $41 vs. today's $41.04.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $43.19 | $950.22 | -5.0% |
| 1 month ago | $36.54 | $1,123.15 | +12.3% |
| 3 months ago | $45.6 | $900 | -10.0% |
| 6 months ago | $42.72 | $960.67 | -3.9% |
| All time ago | $41 | $1,000.98 | +0.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MDLN forecast.
Our base-case forecast reaches $82.00 around 2034.
Implied market cap at $82.00: $69.34B
In the multi-year view, the forecast shows a clear upward trajectory. The 2030 outlook sits at an average price of $70.12 with a bullish sentiment and a 68 ROI. The 2040 outlook increases to an average of $126.49 with a 203.1 ROI, and the 2050 outlook reaches an average of $276.12 with a 561.7 ROI, illustrating substantial long-run upside.
Along the way, the sequence includes 2031 average $69.36 with ROI 66.2 and 2032 average $75.34 with ROI 80.5, continuing through 2035 at an average of $103.23 with ROI 147.4, then extending to 2040 and 2050 with the large-scale increases noted.
These are estimates and not guarantees; they imply a bullish long-term path but depend on market conditions and other factors.
Tap a question to reveal the answer.
2030 min $48.46, avg $70.12, max $110.01 with ROI 68 and sentiment BULLISH.
The forecast shows rising averages and positive ROIs in coming years, including 2027 ROI 18.6, 2028 ROI 30.5, 2029 ROI 55.5, 2030 ROI 68, 2040 ROI 203.1, and 2050 ROI 561.7, with a bullish sentiment. These are estimates, not guarantees.
Yes — the 2030 max is $110.01, and the 2029 max is $98.70, meaning a rise above $100 could occur by 2030 according to the forecast.
Current price $41.73 and market cap $74.35B.
The 30-day range is $35.34 to $49.27. Support is at $33.19 and resistance at $41.73.
Medline Inc. Community Discussion
0Share your Medline Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.